Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Ketogenic Diet with Radiation and Temozolomide in Glioblastoma
NCT03451799Phase 1Completed
- Start
- Apr 2018
- Primary completion
- Sep 2021
- Countries
- 1
01
Overview
Phase 1, open-label, single-arm trial in glioblastoma (GBM). Primary endpoint: Safety of the intervention at 4 months. Started Apr 2018; status: completed.
02
Conditions
glioblastoma (GBM)
Beyond the preview
Go deeper on NCT03451799.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT03451799.